EPISODE · Mar 29, 2022 · 9 MIN
Immunotherapy Combinations for First-Line Advanced NSCLC Treatment: Clinical Insights on Current and Emerging Options
from PeerVoice Clinical Pharmacology Video · host PeerVoice
Immunotherapy Combinations for First-Line Advanced NSCLC Treatment: Clinical Insights on Current and Emerging Options
Embed this episode
What this episode covers
Visit https://www.peervoice.com/QHT860 to view the entire programme with slides. After completing “Immunotherapy Combinations for First-Line Advanced NSCLC Treatment: Clinical Insights on Current and Emerging Options”, participants will be able to: Describe the role of immunotherapy-based combinations in the first-line treatment of patients with advanced non–small-cell lung cancer (NSCLC); Discuss the latest evidence of immunotherapy-based combinations in advanced NSCLC.
Ready to play
Immunotherapy Combinations for First-Line Advanced NSCLC Treatment: Clinical Insights on Current and Emerging Options
No transcript for this episode yet
Similar Episodes
No similar episodes found.